Sort
21,281 grants matching “influenza”
The Role of Epstein Barr Virus in Systemic Lupus Erythematosus
$122,915Timothy E Quan · Yale University · K08 · FY2007 · AR
Virus-Host Interactions in Eukaryotic Cells
$122,863Univ Of Med/Dent Nj-R W Johnson Med Sch · T32 · FY2004 · AI
Integrative Multi-Scale Systems Analysis of Gene-Expression-Driven Aging Morbidity
$122,861Thomas Stoeger · Northwestern University · K99 · FY2020 · AG
Integrative Multi-Scale Systems Analysis of Gene-Expression-Driven Aging Morbidity
$122,861Thomas Stoeger · Northwestern University · K99 · FY2021 · AG
Discovery and characterization of protective Influenza Type B Virus neuraminidase antibodies
$122,850Rachael Wolters · Vanderbilt University · K01 · FY2023 · OD
Discovery and characterization of protective Influenza Type B Virus neuraminidase antibodies
$122,850Rachael Wolters · Oregon Health & Science University · K01 · FY2025 · OD
Discovery and characterization of protective Influenza Type B Virus neuraminidase antibodies
$122,850Rachael Wolters · Oregon Health & Science University · K01 · FY2024 · OD
Cultural Competency Training in Latino Health
$122,736Desiree Annabel Lie · University Of California-Irvine · K07 · FY2007 · HL
Reversing HIV-induced B cell dysfunction with bisphosphonates
$122,664Kehmia Nubonyin Titanji · Emory University · K01 · FY2019 · HL
Role of viral mitophagosomes in driving sex differences in myocarditis
$122,438Delisa Fairweather · Mayo Clinic Jacksonville · R21 · FY2020 · AI
IDENT TOLL LIKE RECEPTORS AGONIST INDUCED PBMC & CD8+T CELLS ANT-I HIV MECHANISM
$122,406Nawal Boukli · Universidad Central Del Caribe · G12 · FY2013 · MD
IMMUNOMODULATOR-MEDIATED ENHANCEMENT OF ANTI-HIV-SPECIFIC IMMUNE RESPONSE
$122,406Miguel Otero · Universidad Central Del Caribe · G12 · FY2013 · MD
Influenza virus assembly and virulence
$122,400Andrew S. Pekosz · Johns Hopkins University · R01 · FY2007 · AI
Creating Innovative Vaccine Messaging by Engaging in Patient-Centered Design with Non-Vaccinating Older Adults
$122,211Aaron Michael Scherer · University Of Iowa · K01 · FY2024 · AG
Creating Innovative Vaccine Messaging by Engaging in Patient-Centered Design with Non-Vaccinating Older Adults
$122,183Aaron Michael Scherer · University Of Iowa · K01 · FY2022 · AG
Combinational Regulation of Inflammation in Otitis Media
$122,151Jian-Dong Li · University Of Rochester · R01 · FY2010 · DC
Creating Innovative Vaccine Messaging by Engaging in Patient-Centered Design with Non-Vaccinating Older Adults
$122,139Aaron Michael Scherer · University Of Iowa · K01 · FY2023 · AG
Creating Innovative Vaccine Messaging by Engaging in Patient-Centered Design with Non-Vaccinating Older Adults
$122,043Aaron Michael Scherer · University Of Iowa · K01 · FY2020 · AG
Task A56:Mouse Model of Low-pathogenic Seasonal and Pandemic Influenza
$122,000Morrey John · Utah State University · N01 · FY2014 · AI
Creating Innovative Vaccine Messaging by Engaging in Patient-Centered Design with Non-Vaccinating Older Adults
$121,995Aaron Michael Scherer · University Of Iowa · K01 · FY2021 · AG
Role of the Epithelial Growth Factor Receptor in SARS Coronavirus Pathogenesis
$121,986Matthew Bryan Frieman · University Of Maryland Baltimore · R01 · FY2016 · AI
A MICROCARRIER/CEF/MEDIA SYSTEM TO MAKE VIRAL VACCINES
$121,855Solohill Engineering, Inc. · R43 · FY2000 · AI
CSL - INF 0506
$121,832Kathryn Margaret Edwards · Vanderbilt University · M01 · FY2007 · RR
Interventions that Retard Mammalian Aging
$121,763David E Harrison · Jackson Laboratory · U01 · FY2021 · AG
Function and Mechanism of Viperin, a radical SAM antiviral protein
$121,679Steven C. Almo · Albert Einstein College Of Medicine, Inc · R21 · FY2018 · AI